
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued an advisory cautioning against the indiscriminate, repeated or prolonged use of painkillers (NSAIDs) and antibiotics. The advisory highlights the risk…
India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has issued an advisory cautioning against the indiscriminate, repeated or prolonged use of painkillers (NSAIDs) and antibiotics. The advisory highlights the risk of avoidable renal complications and chronic kidney disease from inappropriate use. The regulator said these medicines should only be used when clinically indicated, at the appropriate dose and duration, and under medical supervision.

The CDSCO advised the public not to use NSAIDs or antibiotics without medical advice, not to self-medicate with antibiotics, and not to share leftover medicines. Healthcare professionals have been asked to prescribe these drugs only when clinically needed, to consider the lowest effective dose of NSAIDs, and to follow antimicrobial stewardship principles for antibiotics. Pharmacists and retailers have been directed to comply with prescription requirements for Schedule H and H1 drugs.

The advisory is a regulatory reminder of existing rules rather than a new policy. All three outlets reported the CDSCO circular in a neutral, factual tone, with no political or ideological slant. The coverage uniformly stressed the health risk of chronic kidney disease from overuse, the need for medical supervision, and compliance with the Drugs and Cosmetics Act. The key detail is the regulator's directive to state drug authorities to create public awareness and ensure enforcement, which will be measured by compliance audits in the coming months.
Coverage: 3 sources, 3 neutral
Sources (3): economictimes.indiatimes.com (neutral report), deccanherald.com (neutral report), greaterkashmir.com (neutral report)
This brief was synthesised by AI from the 3 sources linked above, so one read covers every framing they carry.
Updated: this story now draws on 3 sources.